Thomas Gossas

733 total citations
21 papers, 583 citations indexed

About

Thomas Gossas is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Thomas Gossas has authored 21 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Thomas Gossas's work include HIV/AIDS drug development and treatment (7 papers), Peptidase Inhibition and Analysis (5 papers) and Hepatitis C virus research (4 papers). Thomas Gossas is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Peptidase Inhibition and Analysis (5 papers) and Hepatitis C virus research (4 papers). Thomas Gossas collaborates with scholars based in Sweden, France and Spain. Thomas Gossas's co-authors include U. Helena Danielson, Tony Christopeit, Xiongyu Wu, Mats Larhed, Eva Åkerblom, Yogesh Sabnis, Susanne Nyström, Anja Sandström, Markku Hämäläinen and Per Källblad and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Biochemistry.

In The Last Decade

Thomas Gossas

20 papers receiving 567 citations

Peers

Thomas Gossas
Kaapjoo Park United States
Todd W. Rockway United States
Mary M. Senior United States
Rajeshri G. Karki United States
Jenny Wai United States
Rebecca Rone United States
Luc J. Farmer United States
Zhi‐Jie Ni United States
Thomas Gossas
Citations per year, relative to Thomas Gossas Thomas Gossas (= 1×) peers Anja Sandström

Countries citing papers authored by Thomas Gossas

Since Specialization
Citations

This map shows the geographic impact of Thomas Gossas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gossas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gossas more than expected).

Fields of papers citing papers by Thomas Gossas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gossas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gossas. The network helps show where Thomas Gossas may publish in the future.

Co-authorship network of co-authors of Thomas Gossas

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gossas. A scholar is included among the top collaborators of Thomas Gossas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gossas. Thomas Gossas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geitmann, Matthis, Thomas Gossas, Ulf Bremberg, et al.. (2025). Abstract LB238: Expanding the TEAD therapeutic potential with degraders: In vitro sensitivity, predictive biomarkers, and in vivo efficacy. Cancer Research. 85(8_Supplement_2). LB238–LB238.
2.
Geitmann, Matthis, Thomas Gossas, Ulf Bremberg, et al.. (2024). Abstract LB029: Degraders of TEAD transcription factors based on interface 3 binders. Cancer Research. 84(7_Supplement). LB029–LB029. 1 indexed citations
3.
Wohlfart, Paulus, et al.. (2019). Comparison of metabolic and mitogenic response in vitro of the rapid-acting insulin lispro product SAR342434, and US- and EU-approved Humalog®. Regulatory Toxicology and Pharmacology. 109. 104497–104497. 5 indexed citations
4.
Spurný, Radovan, Sarah Debaveye, Ann Vos, et al.. (2015). Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptor. Proceedings of the National Academy of Sciences. 112(19). E2543–52. 87 indexed citations
6.
7.
Gossas, Thomas, Lotta Vrang, Ian Henderson, et al.. (2011). Aliskiren displays long-lasting interactions with human renin. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(2). 219–224. 5 indexed citations
8.
Nonglaton, Guillaume, Frank Büttner, Karin D. Caldwell, et al.. (2011). Powerful Protein Binders from Designed Polypeptides and Small Organic Molecules—A General Concept for Protein Recognition. Angewandte Chemie International Edition. 50(8). 1823–1827. 16 indexed citations
9.
Christopeit, Tony, Gun Stenberg, Thomas Gossas, et al.. (2011). A surface plasmon resonance-based biosensor with full-length BACE1 in a reconstituted membrane. Analytical Biochemistry. 414(1). 14–22. 17 indexed citations
10.
Nonglaton, Guillaume, Frank Büttner, Karin D. Caldwell, et al.. (2011). Powerful Protein Binders from Designed Polypeptides and Small Organic Molecules—A General Concept for Protein Recognition. Angewandte Chemie. 123(8). 1863–1867. 3 indexed citations
11.
Christopeit, Tony, M. Carmen Villaverde, Thomas Gossas, et al.. (2010). Effect of the Protonation State of the Titratable Residues on the Inhibitor Affinity to BACE-1. Biochemistry. 49(34). 7255–7263. 47 indexed citations
12.
Geitmann, Matthis, et al.. (2010). Experimental Validation of a Fragment Library for Lead Discovery Using SPR Biosensor Technology. SLAS DISCOVERY. 16(1). 15–25. 25 indexed citations
13.
Christopeit, Tony, Thomas Gossas, & U. Helena Danielson. (2009). Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor. Analytical Biochemistry. 391(1). 39–44. 63 indexed citations
14.
Gossas, Thomas, et al.. (2008). Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety. Bioorganic & Medicinal Chemistry. 16(6). 2955–2967. 18 indexed citations
15.
Gossas, Thomas, et al.. (2007). Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 15(12). 4057–4068. 45 indexed citations
16.
Åkerblom, Eva, Thomas Gossas, Yogesh Sabnis, et al.. (2006). Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors. Bioorganic & Medicinal Chemistry. 15(3). 1448–1474. 41 indexed citations
17.
Gossas, Thomas & U. Helena Danielson. (2006). Characterization of Ca2+ interactions with matrix metallopeptidase-12: implications for matrix metallopeptidase regulation. Biochemical Journal. 398(3). 393–398. 21 indexed citations
18.
Sabnis, Yogesh, Thomas Gossas, Eva Åkerblom, et al.. (2005). Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3. Bioorganic & Medicinal Chemistry. 14(2). 544–559. 44 indexed citations
19.
Wu, Xiongyu, et al.. (2005). Easy-to-Execute Carbonylations:  Microwave Synthesis of Acyl Sulfonamides Using Mo(CO)6 as a Solid Carbon Monoxide Source. The Journal of Organic Chemistry. 70(8). 3094–3098. 74 indexed citations
20.
Gossas, Thomas & U. Helena Danielson. (2003). Analysis of the pH‐dependencies of the association and dissociation kinetics of HIV‐1 protease inhibitors. Journal of Molecular Recognition. 16(4). 203–212. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026